BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26352326)

  • 1. Enhanced molecular dynamics sampling of drug target conformations.
    Rodriguez-Bussey IG; Doshi U; Hamelberg D
    Biopolymers; 2016 Jan; 105(1):35-42. PubMed ID: 26352326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards fast, rigorous and efficient conformational sampling of biomolecules: Advances in accelerated molecular dynamics.
    Doshi U; Hamelberg D
    Biochim Biophys Acta; 2015 May; 1850(5):878-888. PubMed ID: 25153688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Statistical Sampling and Accuracy with Accelerated Molecular Dynamics on Rotatable Torsions.
    Doshi U; Hamelberg D
    J Chem Theory Comput; 2012 Nov; 8(11):4004-12. PubMed ID: 26605567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophilin A inhibition: targeting transition-state-bound enzyme conformations for structure-based drug design.
    Nagaraju M; McGowan LC; Hamelberg D
    J Chem Inf Model; 2013 Feb; 53(2):403-10. PubMed ID: 23312027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving Rigorous Accelerated Conformational Sampling in Explicit Solvent.
    Doshi U; Hamelberg D
    J Phys Chem Lett; 2014 Apr; 5(7):1217-24. PubMed ID: 26274474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein flexibility in ligand docking and virtual screening to protein kinases.
    Cavasotto CN; Abagyan RA
    J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ensemble-based docking using biased molecular dynamics.
    Campbell AJ; Lamb ML; Joseph-McCarthy D
    J Chem Inf Model; 2014 Jul; 54(7):2127-38. PubMed ID: 24881672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of molecular dynamics sampling on the performance of virtual screening against GPCRs.
    Tarcsay A; Paragi G; Vass M; Jójárt B; Bogár F; Keserű GM
    J Chem Inf Model; 2013 Nov; 53(11):2990-9. PubMed ID: 24116387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling correlated main-chain motions in proteins for flexible molecular recognition.
    Zavodszky MI; Lei M; Thorpe MF; Day AR; Kuhn LA
    Proteins; 2004 Nov; 57(2):243-61. PubMed ID: 15340912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating Molecular Docking and Molecular Dynamics Simulations.
    Santos LHS; Ferreira RS; Caffarena ER
    Methods Mol Biol; 2019; 2053():13-34. PubMed ID: 31452096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
    Kumar R; Garg P; Bharatam PV
    J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tackling the conformational sampling of larger flexible compounds and macrocycles in pharmacology and drug discovery.
    Chen IJ; Foloppe N
    Bioorg Med Chem; 2013 Dec; 21(24):7898-920. PubMed ID: 24184215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovering potent small molecule inhibitors of cyclophilin A using de novo drug design approach.
    Ni S; Yuan Y; Huang J; Mao X; Lv M; Zhu J; Shen X; Pei J; Lai L; Jiang H; Li J
    J Med Chem; 2009 Sep; 52(17):5295-8. PubMed ID: 19691347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics in drug design.
    Zhao H; Caflisch A
    Eur J Med Chem; 2015 Feb; 91():4-14. PubMed ID: 25108504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated molecular dynamics in computational drug design.
    Wereszczynski J; McCammon JA
    Methods Mol Biol; 2012; 819():515-24. PubMed ID: 22183555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase.
    Frembgen-Kesner T; Elcock AH
    J Mol Biol; 2006 May; 359(1):202-14. PubMed ID: 16616932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein Flexibility in Docking-Based Virtual Screening: Discovery of Novel Lymphoid-Specific Tyrosine Phosphatase Inhibitors Using Multiple Crystal Structures.
    Hou X; Li K; Yu X; Sun JP; Fang H
    J Chem Inf Model; 2015 Sep; 55(9):1973-83. PubMed ID: 26360643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving docking results via reranking of ensembles of ligand poses in multiple X-ray protein conformations with MM-GBSA.
    Greenidge PA; Kramer C; Mozziconacci JC; Sherman W
    J Chem Inf Model; 2014 Oct; 54(10):2697-717. PubMed ID: 25266271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the use of molecular dynamics receptor conformations for virtual screening.
    Nichols SE; Baron R; McCammon JA
    Methods Mol Biol; 2012; 819():93-103. PubMed ID: 22183532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrichment of druggable conformations from apo protein structures using cosolvent-accelerated molecular dynamics.
    Kalenkiewicz A; Grant BJ; Yang CY
    Biology (Basel); 2015 Apr; 4(2):344-66. PubMed ID: 25906084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.